Unknown

Dataset Information

0

Unique structure and dynamics of the EphA5 ligand binding domain mediate its binding specificity as revealed by X-ray crystallography, NMR and MD simulations.


ABSTRACT: The 16 EphA and EphB receptors represent the largest family of receptor tyrosine kinases, and their interactions with 9 ephrin-A and ephrin-B ligands initiate bidirectional signals controlling many physiological and pathological processes. Most interactions occur between receptor and ephrins of the same class, and only EphA4 can bind all A and B ephrins. To understand the structural and dynamic principles that enable Eph receptors to utilize the same jellyroll ?-sandwich fold to bind ephrins, the VAPB-MSP domain, peptides and small molecules, we have used crystallography, NMR and molecular dynamics (MD) simulations to determine the first structure and dynamics of the EphA5 ligand-binding domain (LBD), which only binds ephrin-A ligands. Unexpectedly, despite being unbound, the high affinity ephrin-binding pocket of EphA5 resembles that of other Eph receptors bound to ephrins, with a helical conformation over the J-K loop and an open pocket. The openness of the pocket is further supported by NMR hydrogen/deuterium exchange data and MD simulations. Additionally, the EphA5 LBD undergoes significant picosecond-nanosecond conformational exchanges over the loops, as revealed by NMR and MD simulations, but lacks global conformational exchanges on the microsecond-millisecond time scale. This is markedly different from the EphA4 LBD, which shares 74% sequence identity and 87% homology. Consequently, the unbound EphA5 LBD appears to comprise an ensemble of open conformations that have only small variations over the loops and appear ready to bind ephrin-A ligands. These findings show how two proteins with high sequence homology and structural similarity are still able to achieve distinctive binding specificities through different dynamics, which may represent a general mechanism whereby the same protein fold can serve for different functions. Our findings also suggest that a promising strategy to design agonists/antagonists with high affinity and selectivity might be to target specific dynamic states of the Eph receptor LBDs.

SUBMITTER: Huan X 

PROVIDER: S-EPMC3782497 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3274464 | BioStudies
2010-01-01 | S-EPMC3947671 | BioStudies
2010-01-01 | S-EPMC2804212 | BioStudies
2013-01-01 | S-EPMC3767517 | BioStudies
2012-01-01 | S-EPMC3438283 | BioStudies
2002-01-01 | S-EPMC123121 | BioStudies
2009-01-01 | S-EPMC2729353 | BioStudies
1000-01-01 | S-EPMC3585520 | BioStudies
2013-01-01 | S-EPMC3839050 | BioStudies
2015-01-01 | S-EPMC4439037 | BioStudies